Patents by Inventor Claude Cochet

Claude Cochet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER
    Publication number: 20230278983
    Abstract: The present invention relates to indole derivatives of formula (I?) as CK2 inhibitor and pharmaceutical compositions comprising the same. The present invention further relates to the use of such compounds of formula (I) for use for preventing and/or treating a cancer.
    Type: Application
    Filed: July 6, 2021
    Publication date: September 7, 2023
    Applicants: Universite Claude Bernard Lyon 1, Institut National de la Sante et de la Recherche Madicale, Centre National de la Recherche Scientifique, Ecole Normale Superieure de Lyon, Commissariat à l'Energie Atomique et aux Energies AlternativesS, Centre Leon Berard
    Inventors: Alexandre Bancet, Claude Cochet, Odile Filhol-Cochet, Isabelle Krimm, Thierry Lomberget, Marc Le Borgne
  • Methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway
    Patent number: 11629192
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway. In particular, the present invention relates to a method for treating a disease selected from the group consisting of cancers, obesity and obesity related diseases, anorexia, autoimmune diseases and infectious diseases in a subject in need thereof comprising administering the subject with a therapeutically effective amount of an antagonist of the NRP-1/OBR signaling pathway.
    Type: Grant
    Filed: September 4, 2018
    Date of Patent: April 18, 2023
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITÉ PARIS CITÉ, FONDATION IMAGINE, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE GRENOBLE ALPES, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, UNIVERSITE DE BOURGOGNE
    Inventors: Zakia Belaid-Choucair, Olivier Hermine, Carmen Garrido-Fleury, Claude Cochet, Odile Filhol-Cochet, Renaud Seigneuric
  • Synthetic lethal drug combination for treating renal cell carcinoma
    Patent number: 10322133
    Abstract: The present invention pertains to a novel treatment of renal cell carcinoma and other a solid tumors which harbor a VHL inactivation, based on the combination of a first agent inhibiting a protein kinase CK2 (CK2) and a second agent inhibiting an Ataxia Telangiectasia Mutated (ATM) kinase.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: June 18, 2019
    Assignees: Commissariat a l'Energie Atomique et aux Energies Alternatives, Institut National de la Sante et de la Recherche Medicale
    Inventors: Sofia Giacosa, Catherine Pillet, Claude Cochet, Odile Filhol, Caroline Barette, Emmanuelle Soleilhac
  • Methods and Pharmaceutical Compositions for the Treatment of Diseases Mediated by the NRP-1/OBR Complex Signaling Pathway
    Publication number: 20190002569
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway. In particular, the present invention relates to a method for treating a disease selected from the group consisting of cancers, obesity and obesity related diseases, anorexia, autoimmune diseases and infectious diseases in a subject in need thereof comprising administering the subject with a therapeutically effective amount of an antagonist of the NRP-1/OBR signaling pathway.
    Type: Application
    Filed: September 4, 2018
    Publication date: January 3, 2019
    Inventors: Zakia Belaid-Choucair, Olivier Hermine, Carmen Garrido-Fleury, Claude Cochet, Odile Filhol-Cochet, Renaud Seigneuric
  • A Synthetic Lethal Drug Combination for Treating Renal Cell Carcinoma
    Publication number: 20180256587
    Abstract: The present invention pertains to a novel treatment of renal cell carcinoma and other a solid tumors which harbor a VHL inactivation, based on the combination of a first agent inhibiting a protein kinase CK2 (CK2) and a second agent inhibiting an Ataxia Telangiectasia Mutated (ATM) kinase.
    Type: Application
    Filed: September 21, 2016
    Publication date: September 13, 2018
    Applicants: Commissariat a l'Energie Atomique et aux Energies Alternatives, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Sofia Giacosa, Catherine Pillet, Claude Cochet, Odile Filhol, Caroline Barette, Emmanuelle Soleilhac
  • Methods and Pharmaceutical Compositions for the Treatment of Diseases Mediated by the NRP-1/OBR Complex Signaling Pathway
    Publication number: 20170051062
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway. In particular, the present invention relates to a method for treating a disease selected from the group consisting of cancers, obesity and obesity related diseases, anorexia, autoimmune diseases and infectious diseases in a subject in need thereof comprising administering the subject with a therapeutically effective amount of an antagonist of the NRP-1/OBR signaling pathway.
    Type: Application
    Filed: February 18, 2015
    Publication date: February 23, 2017
    Inventors: Zakia Belaid-Choucair, Olivier Hermine, Carmen Garrido-Fleury, Claude Cochet, Odile Filhol-Cochet, Renaud Seigneuric
  • In vitro method for diagnosing prostate cancer
    Patent number: 8829162
    Abstract: The invention relates to an in vitro method for diagnosing prostate cancer and to antibodies and fragments thereof directed against CK2-? and their use for the diagnosis and prognosis of prostate cancer.
    Type: Grant
    Filed: January 2, 2008
    Date of Patent: September 9, 2014
    Assignees: Inserm (Institut National de la Sante et de la Recherche Medicale), Commissariat a l'Energie Atomique
    Inventors: Claude Cochet, Odile Filhol, Mathieu Laramas
  • Condensed pyridine derivatives useful as potent inhibitors of the protein kinase CK2
    Patent number: 8686144
    Abstract: The invention relates to the use of specific compounds of formula (I) and their pharmaceutically-acceptable salts: (Formula 1) (I) as a new family of protein kinase CK2 inhibitors; the invention also relates to the use of compounds of formula (I) for the preparation of pharmaceutical compositions for the prevention and/or treatment of disorders and/or diseases chosen amongst cancers; autoimmune and inflammatory diseases; infectious diseases; diabetes angiogenesis related disorders; retinopathies and cardiac hypertrophy.
    Type: Grant
    Filed: July 28, 2010
    Date of Patent: April 1, 2014
    Assignees: Commissariat a l'Energie Atomique et aux Energie Alternative, Institut National de la Sante et de la Recherche Medicale (INSERM), Institut Curie, Centre National de la Recherche Scientifique
    Inventors: Claude Cochet, Renaud Prudent, Virginie Moucadel, Chi-Hung N'guyen
  • CONDENSED PYRIDINE DERIVATIVES USEFUL AS POTENT INHIBITORS OF THE PROTEIN KINASE CK2
    Publication number: 20120178759
    Abstract: The invention relates to the use of specific compounds of formula (I) and their pharmaceutically-acceptable salts: (Formula 1) (I) as a new family of protein kinase CK2 inhibitors; the invention also relates to the use of compounds of formula (I) for the preparation of pharmaceutical compositions for the prevention and/or treatment of disorders and/or diseases chosen Camongst cancers; autoimmune and inflammatory diseases; infectious diseases; diabetes angiogenesis related disorders; retinopathies and cardiac hypertrophy.
    Type: Application
    Filed: July 28, 2010
    Publication date: July 12, 2012
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENE ALT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT CURIE, INSTITUT NAT DE LA SAN ET DE LA RECH MED (INSERM)
    Inventors: Claude Cochet, Renaud Prudent, Virginie Moucadel, Chi-Hung N'guyen
  • Small interfering RNA specific to sub-units ?, ??and ? of the Kinase Protein ck2, and the applications of the same
    Patent number: 8106179
    Abstract: The invention relates to small interfering RNA specific to sub-units ?, ?? and ? of the kinase protein CK2, and to the applications of the same, especially for treating cancer and viral illnesses.
    Type: Grant
    Filed: July 2, 2004
    Date of Patent: January 31, 2012
    Assignees: Commissariat a l'Energie Atomique, Institut National de la Sante et de la Recherche Medicale
    Inventors: Béatrice Schaack, Claude Cochet, Odile Filhol-Cochet, Brigitte Fouque
  • In Vitro Method for Diagnosing Prostate Cancer
    Publication number: 20100136576
    Abstract: The invention relates to an in vitro method for diagnosing prostate cancer and to antibodies and fragments thereof directed against CK2-? and their use for the diagnosis and prognosis of prostate cancer.
    Type: Application
    Filed: January 2, 2008
    Publication date: June 3, 2010
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE
    Inventors: Claude Cochet, Odile Filhol, Mathieu Laramas
  • Small Interfering RNA Specific to Sub-Units $g(a),$g(a)' and $g(b) of the Kinase Protein ck2,and the Applications of the Same
    Publication number: 20070219148
    Abstract: The invention relates to small interfering RNA specific to sub-units ?, ? and ? of the kinase protein CK2, and to the applications of the same, especially for treating cancer and viral illnesses.
    Type: Application
    Filed: July 2, 2004
    Publication date: September 20, 2007
    Applicants: Commissariat A L'energie Atomique, Institut Nat De La Sante et De La Recherche Med
    Inventors: Beatrice Schaack, Claude Cochet, Odile Filhol-Cochet, Brigitte Fouque
  • Method and apparatus for filling drums with immiscible liquids such as white phosphorus and water
    Patent number: 5477898
    Abstract: A drum is filled with two liquids of different densities which are immiscible when combined, such as white phosphorus and water. The drum is positioned on a scale beneath a fill pipe. An actuator lowers the fill pipe into the drum. A quantity of water is injected, followed by a quantity of white phosphorus, followed by a quantity of water to rinse the fill pipe. The fill pipe is raised just out of the liquids and allowed to drip, and then is fully raised to enable the filled drum to be replaced by an empty drum. The white phosphorus is injected at varying flow rates.
    Type: Grant
    Filed: November 29, 1994
    Date of Patent: December 26, 1995
    Assignee: Societe Atochem
    Inventors: Michel Miscevic, Claude Cochet
  • Method and apparatus for filling drums with immiscible liquids such as white phosphorus and water
    Patent number: 5213140
    Abstract: A drum is filled with two liquids of different densities which are immiscible when combined, such as white phosphorus and water. The drum is positioned on a scale beneath a fill pipe. An actuator lowers the fill pipe into the drum. A quantity of water is injected, followed by a quantity of white phosphorus, followed by a quantity of water to rinse the fill pipe. The fill pipe is raised just out of the liquids and allowed to drip, and then is fully raised to enable the filled drum to be replaced by an empty drum. The white phosphorus is injected at varying flow rates.
    Type: Grant
    Filed: November 22, 1991
    Date of Patent: May 25, 1993
    Assignee: Atochem
    Inventors: Michel Miscevic, Claude Cochet